CompletedPhase 2Phase 3ACTRN12606000162516

Randomised placebo controlled trial on the safety and efficacy of BSP-201 in osteoarthritis

Randomised placebo controlled trial on the safety and efficacy to reduce pain, stiffness and physical disfunction of a Sheabutter Extract (BSP-201) in osteoarthritis

Sponsor

BSP Pharma A/S (this is the full name of company)

Enrollment

128 participants

Start Date

May 5, 2006

Study Type

Interventional

Conditions

Osteoarthritis of the knees and/or hips

Summary

The purpose of the study is to determin the safety, efficacy and potential modes of action of BSP-201 in adults with osteoarthritis of the knees and/or hips. It will be a randomised, double-blind (both subjects and investigators are blinded), placebo-controlled, parallel study.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying: Randomised placebo controlled trial on the safety and efficacy of BSP-201 in osteoarthritis. It may be open to adults aged 18 and older. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

2250mg/day Sheabutter extract (BSP-201) capsules over a 15 week period

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000162516